You're Eating Vitamin C, Your Body Isn't Absorbing It. Here's Why.

SLC23A1 encodes a sodium-dependent vitamin C transporter that sits on the surface of your cells. Its job is straightforward: grab vitamin C from your bloodstream and pump it into the cell where it does actual work. This is an active process that requires energy, and it’s highly selective. Without this transporter working well, vitamin C stays stuck outside your cells, circulating uselessly while your tissues are starved for it.

The SLC23A1 gene has several common variants that reduce transporter function. Roughly 20 to 30 percent of the population carries one of these variants. When you have a compromised version of this gene, your cells require significantly higher dietary vitamin C to achieve the same internal concentration that someone with a normal transporter gets easily. This is why you can take a standard 500 mg supplement and feel no better, while your friend takes half that and feels fine.

You experience this as stubborn fatigue that doesn’t respond to vitamin C supplementation at normal doses, slow-healing cuts and wounds, frequent infections, bleeding or swollen gums, and easy bruising. Your cells are simply not getting enough of the nutrient to support collagen synthesis, immune function, and energy production. No amount of dietary change fixes a broken transporter.

MTHFR encodes an enzyme critical to the methylation cycle, a fundamental biochemical pathway that runs constantly in every cell. This enzyme converts folate into its active form, methylfolate, which then drives the methylation cycle that produces energy, regulates gene expression, and supports detoxification. Vitamin C works downstream of this pathway. If the methylation cycle is sluggish due to MTHFR dysfunction, the whole nutrient utilization system becomes inefficient.

Approximately 40 percent of people of European descent carry at least one copy of the C677T MTHFR variant, which reduces enzyme function by 35 to 70 percent depending on how many copies you carry. With a compromised MTHFR, your cells struggle to recycle and regenerate the active forms of folate and B12 needed to support the methylation cycle, which then cascades into poor vitamin C utilization even if transport is normal. Your cells become inefficient at every nutrient processing step.

You experience this as fatigue that doesn’t fully resolve with diet changes alone, brain fog, mood instability, and a pervasive sense that your body is not converting food into usable energy efficiently. If you also have the SLC23A1 variant, the problem is compounded. Your cells can’t transport vitamin C well, and even the vitamin C that does get in doesn’t get used efficiently because your methylation cycle is sluggish.

VDR encodes the vitamin D receptor, a protein found in virtually every cell in your body. This receptor acts like a master control switch for hundreds of genes, including genes involved in nutrient transport, immune function, and bone health. When vitamin D binds to this receptor, it tells your cells to activate specific nutrient-handling pathways. If your VDR is less sensitive due to genetic variation, this entire communication system becomes sluggish.

Roughly 30 to 50 percent of the population carries a VDR variant, most commonly the BsmI or FokI polymorphisms. People with certain VDR variants require significantly higher vitamin D levels to achieve the same biological effect as someone with a normal receptor. Since vitamin D regulates the expression of nutrient transporters including vitamin C transporters, a sluggish VDR means reduced vitamin C transport efficiency even if your SLC23A1 gene is normal.

You experience this as vitamin D supplementation that doesn’t seem to work despite high doses, persistent fatigue and low mood even during sunny months, slow wound healing, and weak immune function. If you also have SLC23A1 or MTHFR variants, your vitamin C status suffers because your VDR is not adequately upregulating the transporter genes that pull vitamin C into your cells.

GC encodes the vitamin D binding protein (VDBP), which transports vitamin D through your bloodstream and delivers it to tissues. Think of it as the delivery truck for vitamin D. VDBP comes in several common variants (1s, 1f, and 2), and they differ in how much vitamin D they bind tightly versus leave free and available to tissues. This matters because only free vitamin D can actually enter cells and activate the VDR we just discussed.

These variants are common in all populations, but their distribution varies. Certain GC haplotypes bind vitamin D more tightly, leaving less free vitamin D available to your tissues even when your total blood vitamin D looks adequate. This creates a paradox: normal lab results but poor tissue-level vitamin D function, which then cascades into reduced vitamin C transporter expression and poor vitamin C absorption.

You experience this as symptoms of vitamin D deficiency despite taking supplements, and accompanying vitamin C deficiency symptoms like fatigue and poor wound healing. Your bloodwork shows adequate or even high vitamin D, but your cells are not getting the message because the binding protein is holding vitamin D too tightly. The free vitamin D that is available is being used for survival functions, leaving less resources for nutrient transporter regulation.

BCMO1 encodes beta-carotene 15,15′-monooxygenase, an enzyme that converts plant-based beta-carotene (the precursor found in carrots, sweet potatoes, and leafy greens) into retinol, the active form of vitamin A your cells actually use. This conversion step is not 100 percent efficient even in people with normal enzyme function. Your body has to break down the beta-carotene molecule and then regenerate it as retinol. The process wastes a lot of substrate.

Roughly 45 percent of the population carries a BCMO1 variant (R267S or A379V) that further reduces this conversion efficiency. People with these variants convert beta-carotene to retinol at only 20 to 40 percent of the rate of people with normal BCMO1. If you rely entirely on plant sources for vitamin A, you are functionally deficient regardless of how many carrots you eat.

You experience this as poor vitamin C absorption symptoms plus vitamin A deficiency symptoms: night blindness, dry skin, poor immune function, and slow wound healing. Vitamin C and vitamin A work together in collagen synthesis and immune defense. If you are deficient in vitamin A due to poor BCMO1 function, your vitamin C status suffers because your body is trying to do too much repair work with insufficient resources from both nutrients.

FUT2 encodes a fucosyltransferase enzyme that determines what sugars are present on the surface of cells lining your digestive tract. This might sound obscure, but it is profoundly important because these sugars act like food and habitat markers for your gut bacteria. Different FUT2 variants create different chemical environments in your gut, which attracts different bacterial species and changes your microbiome composition.

Approximately 40 percent of people carry FUT2 variants that reduce fucosyltransferase activity (the nonsecretor phenotype). This change in gut bacteria composition alters your microbiome’s ability to produce short-chain fatty acids, synthesize B vitamins, and regulate the integrity of your intestinal barrier. A compromised gut barrier means reduced absorption of all nutrients including vitamin C, even if everything else is normal.

You experience this as vitamin C and other micronutrient symptoms (fatigue, poor wound healing, frequent infections) plus digestive symptoms like bloating, loose stools, or constipation. Your gut is not absorbing nutrients efficiently because the bacterial ecosystem is imbalanced. FUT2 cannot be changed, but the microbiome can be actively restored with targeted prebiotics and probiotics that support bacterial diversity.